The endoscopes market, although young, has reached maturity in a short time span. The key challenges include facility and surgeon consolidation and price erosion. Companies need to establish long-term relationships with end users and create a brand image in order to ensure continued growth and support from end users.
New analysis from Frost & Sullivan U.S. Endoscopes Market, reveals that revenues in this industry totaled $449.96 million in 2005 and estimates this to reach $513.46 million in 2012.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Endoscopes Market, then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.
“Endoscopic diagnostic and surgical procedures have seen a prominent boost since 2002 due to reimbursement for office based procedures. Most diagnostic procedures can be efficiently performed in the physician office, thus reducing the load on hospitals and offering a more convenient and less expensive option to patients,” says Frost & Sullivan Healthcare Industry Manager Vaishnavi Ananthanarayanan.
In the past, E.N.T. procedures were performed in hospitals, but since they were minor procedures it was a waste of resources and space. Moreover, patients also found it cumbersome to go through all the other formalities in a hospital for minor E.N.T. procedures. Additionally, although most E.N.T. procedures were being performed in the office set up in recent years, they lacked sufficient reimbursement. With a CPT code being assigned in 2003, the restraint due to reimbursement in the office setting has been wiped off, thus resulting in an increased flow of E.N.T. endoscopy procedures in an office.
In recent years the arthroscopy industry, has seen a positive move towards performing small joint arthroscopy as well as certain cases of knee, shoulder and elbow arthroscopy in the ambulatory surgical centers and physician offices.
With heightened focus on office-based procedures for cystoscopy, patients and medical practitioners have greatly accepted office-based urology procedures as a convenient and less-expensive means of treatment.
Consolidation of facilities and specialists puts increased pressure on companies to hold on to their market share. Several facilities have either closed down or tied-up with others to perform certain specialty cases and procedures.
“This consolidation is not only an effort to reduce costs but to bring together a pool of expertise and equipment. Thus, manufacturers are constantly competing to cater to a shrinking pool of end users,” explains Vaishnavi. “Ambulatory surgery centers (ASCs) further help in reducing costs for end users as equipment is often used on a shared basis or refurbished equipment is used.”
Moreover, several specialists such as ENT and pulmonary endoscopists work together as many of the procedures performed are interlinked and require dual expertise and common or similar equipment. All these consolidations prove to be an impending challenge for companies to pitch their product and hold on to existing market share.
Establishing long term contracts with facilities for new purchase and service is the key to overcome the challenge of facility and surgeon consolidation. In a brand conscious market, strong customer service and relationship would help to leverage company market share in spite of transitions and mergers.
U.S. Endoscopes Market is part of the Medical Device subscription, which also includes research in the following markets: Gastrointestinal Endoscopes, Urology & Endourology Endoscopes, Gynecology Endoscopes, Arthroscopes, Neuroendoscopes, ENT Endoscopes, Pulmonary Endoscopes, and Laparoscopes. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available to the press.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.
U.S. Endoscopes Market